PUBLISHED ON: November 7, 2016 | Duration: 29 min, 22 sec
TS Harihar, chief executive and founder at HRBV Client Solutions, says the core concerns about Ranbaxy integration are now behind. He does not see much impact to Sun Pharma from US government investigations into the pricing of drugs.
